BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Hematopoietic cell
,
Cisplatin
,
rs2300478
,
MYC
,
T cell differentiation
,
Breast Cancer
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
TYR 1
Summary
General Info
Curated Studies
Most Correlated Studies
Calvaria of wildtype and b-arrestin knockouts treated with G Protein-Coupled Receptor Agonist
Osteocyte-like IDG-SW3 cells after PTH treatment
Irides of mouse models for albinism, pigment dispersion syndrome, and exfoliation syndrome
Cutaneous melanomas derived from induced expression of Met or HRAS
Hippocampal gene expression in a mouse model for Potocki-Lupski Syndrome
Explore Curated Studies Results
Literature
Most Relevant Literature
GHRH agonist MR-409 protects β-cells from streptozotocin-induced diabetes.
Growth hormone-releasing hormone antagonistic analog MIA-690 stimulates food intake in mice.
UVB-Induced Secretion of IL-1β Promotes Melanogenesis by Upregulating TYR/TRP-1 Expression In Vitro.
Effects of growth hormone-releasing hormone agonistic analog MR-409 on insulin-secreting cells under…
Tyramine and its receptor TYR1 linked behavior QTL to reproductive physiology in honey bee workers (…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Evaluation of TYR Sphere in France
Evaluation of TYR Sphere
GMP Case Studies of Tolerance, Safety and Acceptability in PKU and TYR
Efficacy of 177-Lu-DOTA 0, Tyr 3 Octreotate
A Physiological Study to Determine the Enteral Threonine Requirements in Infants Aged 1 to 6 Months
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ